Christian Chabannon (@CChabannon) header
Christian Chabannon (@CChabannon) profile picture

Hematologist. Stem cell transplantation and CAR-T Cells specialist. Jazz lover. Organ donor. Opinions are my own

Marseille, France
Joined April 2017
Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)Photo by Christian Chabannon (@CChabannon)
Christian Chabannon retweeted
👏 Toutes nos félicitations à la Dre Suzette Delaloge pour sa nomination à la présidence de l'Institut national du cancer. À compter du 1er juillet 2026, la Dre Suzette Delaloge prendra la présidence du Conseil d'administration de l'Institut national du cancer (INCa), une reconnaissance de son engagement de longue date au service de la prévention, de la recherche et des patients. À Gustave Roussy, elle a marqué l'Institut par son implication en faveur d'une oncologie toujours plus innovante et personnalisée. À travers le programme Interception, qu'elle dirige depuis 2021, elle a contribué à faire émerger une nouvelle approche de la prévention des cancers fondée sur l'identification précoce des personnes à risque. Son expertise scientifique, son engagement auprès des patients et sa vision d'une cancérologie plus préventive, plus équitable et plus humaine ont profondément contribué à faire avancer la lutte contre le cancer. Nous la remercions chaleureusement pour tout ce qu'elle a apporté à Gustave Roussy et lui souhaitons beaucoup de réussite dans ses nouvelles fonctions au service de tous. Félicitations, Dre Suzette Delaloge !
3
20
4
93
21,692
Authors of this paper offer reassuring real-world evidence for clinicians treating lymphoma patients with prior #HBV exposure, showing that, with antiviral prophylaxis, occult HBV infection should not preclude anti-CD19 #CAR-T therapy. bit.ly/4tTOoQ2
4
5
639
Important milestone for the field: CARsgen’s satri-cel, an autologous Claudin18.2 CAR T, has been approved in China for Claudin18.2+ HER2- advanced gastric/GEJ adenocarcinoma after ≥2 prior lines. CAR T has transformed blood cancers. Solid tumors have been the harder frontier: trafficking, persistence, antigen heterogeneity, and the tumor microenvironment. This approval does not mean the problem is solved, but it shows that engineered T cells can make it across the solid tumor line. Now the work turns to durability, safety, access, earlier lines, combinations, and whether this can extend to other Claudin18.2+ tumors. prnewswire.com/news-releases…
2
16
2
32
5,017
Christian Chabannon retweeted
Packed room. Endless enthusiasm. The IMWG Meeting in Stockholm is a powerful reminder that the myeloma community remains united by one mission: delivering better outcomes for all patients.
2
13
1
67
3,303
Christian Chabannon retweeted
📢 Now available: @FACTcelltherapy and #JACIE 9th Edition HCT Standards + 3rd Edition IEC Standards! 👏 A key milestone and example of the ongoing commitment to promoting high quality and patient safety in #HCT and #CellularTherapy worldwide. ⤵️  📌 ebmt.org/ebmt/news/fact-and-…
17
1
21
7,898
Christian Chabannon retweeted
🔍 FACT-JACIE Standards require alignment across Clinical, Collection, and Processing Units (B1.2 & C1.2). ☑️ All participating units must operate under certified conditions to ensure the highest standards of patient care and safety. 💡 Read more: ebmt.org/ebmt/news/ensuring-…
2
3
101
Christian Chabannon retweeted
📘 Coming soon: A major milestone for the #HCT and #CellularTherapy community! The new FACT-JACIE International Standards (HCT 9 and IEC 3) mark three years of global collaboration to advance quality, safety and best practice in cellular therapies. ⬇️ ebmt.org/ebmt/news/fact-and-…
1
4
7
551
Christian Chabannon retweeted
Celebrating 35 years of academic excellence! The IFM has led groundbreaking trials shaping the modern era of high-dose therapy in myeloma. Proud to see this legacy highlighted in ⁦@BloodCancerJnl⁩ , showcasing how IFM research has set global standards for myeloma care.
5
21
1
90
5,457
Christian Chabannon retweeted
🧬 We unite with key stakeholders across the European healthcare ecosystem to safeguard the #HospitalExemption for Advanced Therapy Medicinal Products (ATMPs). 📣 This Joint Position Statement puts forward the key recommendations to secure a fair, balanced, and effective regulatory environment for HE-ATMPs — one that sustains innovation, protects patient access, and strengthens Europe’s capacity to deliver advanced therapies for all. Read more ⬇️ 🔗 ebmt.org/ebmt/news/safeguard…
1
1
4
564
Christian Chabannon retweeted
🏆𝘁𝗵𝗲 𝗜𝗔𝗖𝗛 𝟮𝟬𝟮𝟱 𝗔𝘄𝗮𝗿𝗱 𝗖𝗲𝗿𝗲𝗺𝗼𝗻𝘆 𝘛𝘩𝘦 𝘳𝘦𝘤𝘪𝘱𝘪𝘦𝘯𝘵 𝘰𝘧  𝘁𝗵𝗲 𝗖𝗵𝗿𝗶𝘀𝘁𝗶𝗮𝗻 𝗖𝗮𝗶𝗹𝗹𝗶𝗼𝘁 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝘄𝗮𝗿𝗱 is 𝗣𝗿𝗼𝗳. 𝗔𝗻𝗻𝗮𝗹𝗶𝘀𝗮 𝗥𝘂𝗴𝗴𝗲𝗿𝗶 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴! @Mohty_EBMT @nagler_EBMT @TheIACH #IACH #Hematology #Myeloma #Lymphoma #MPN #CellTherapy #StemCellTransplant
1
6
2
22
4,750
Christian Chabannon retweeted
#Badinter #Panthéon «Le fascisme ne se lève pas comme la tempête en une nuit. D’abord rampant, dissimulé, ordinaire, il progresse par les voix de la haine, avivée par les difficultés économiques. Il s’empare des cœurs avant de pervertir les esprits puis de prendre le pouvoir»☝️
285
1,518
67
3,602
139,548
Christian Chabannon retweeted
🗓️ The 3rd Practice Harmonisation and Guidelines Committee meeting took place in Berlin end of September, bringing together experts from across Europe and beyond. 🌐 With: 👩‍🏫 12 parallel workshops 👥 100+ participants from 🌍 22 countries, This event fostered collaboration, advancing dialogue and pratice harmonisation in #HCT and #CellTherapy. Thank you to everyone who joined! #MedicalGuidelines #Collaboration #Research
5
1
16
1,200
Christian Chabannon retweeted
Let’s cut it out - HIV from cells CRISPER ly
The end of HIV infections may be closer than we think. Scientists cut HIV out of immune cells using CRISPR. And the cells stayed HIV-free even after re-exposure. A cure could finally be within reach. In a groundbreaking advance, scientists at Temple University have successfully used CRISPR/Cas9 gene editing to eliminate HIV-1 DNA from the genomes of human immune cells. Unlike existing treatments that suppress the virus, this method completely removes the genetic blueprint of HIV from infected T-cells.
1
5
482
Christian Chabannon retweeted
A World First in Hematology Education ⁦@TheIACH⁩ is proud to announce the first-ever AI-generated live webinar in hematology. Harnessing the power of AI, this event will deliver a glimpse into the future. Join us at this historic milestone where innovation meets hematology.
12
2
27
5,781
Gamma delta (γδ) T cells, constituting 5%–10% of peripheral blood lymphocytes, are pivotal in tumor immunosurveillance and are enriched in epithelial tissues. Their unique antigen recognition makes them ideal for allogeneic cell therapy products, with several clinical trials currently underway. This comprehensive review provides an overview of the rationale for γδ T-cell therapy, ongoing clinical trials, as well as the challenges and future role of γδ T-cell-based immune therapies in hematology. Read in-depth here👉f.mtr.cool/bmxigkwbgk
3
12
1,041
Christian Chabannon retweeted
📣 Register early and submit your abstract for #EBMT26 – join us in Madrid for Europe’s largest congress in #HCT and #CellTherapy. 📽️ Hear the welcome from @RDuarte_EBMT and Isabel Salcedo 📌 Check out Early Bird discounts, and 🌍 Get ready to connect with 6,200+ colleagues from across the globe in March 2026. ⬇️ ebmt.org/annual-meeting-2026
12
18
1,587
Christian Chabannon retweeted
🎉 Celebrating the anniversary of the EBMT Registry Since the current system went live in August 2023: 📊 65,000+ new patients added 📈 790,000+ total patient records 💡 73,400+ treatments registered Thank you to our community for making this possible! 🌍 Read more about the milestone ⬇️ ebmt.org/ebmt/news/marking-a… #EBMTRegistry #HCT #CellTherapy #ClinicalResearch #PatientCare
10
21
2,088
Patients with relapsed or refractory primary or secondary CNS lymphoma face a poor prognosis. This study of 100 patients treated with anti-CD19 CAR T-cell therapy showed promising results, supporting its use for these patients despite the risk of severe neurotoxicity. Read more👉bit.ly/4kudEbp
7
25
2,359
10
32
2,278
Christian Chabannon retweeted
Didn't register yet? Don't miss the CAR-T day
🚀 Get ready for an inspiring thursday morning at CAR T day! Day 1 kicks off with a deep dive into the most promising advances in cell therapy and cancer treatment. Expect powerful insights and pioneering perspectives from international experts. 🎯 A glimpse of the program awaits in the visual — you won’t want to miss it. Make sure to register now and secure your place 👉 cartday.org/registration/ We look forward to welcoming you to this unmissable event! #CARTday #CARTday2025 #CARcells #Lille2025 #InternationalEvent #eventprofs @CHU_Lille - @univ_lille - @sfiimmunologie - @i_yakoub_agha - @aljurf100 - @H_Einsele - @LaurieMengerLab - @RoychoudhuriLab - @DrOlivierBoyer
3
2
383